Viewing Study NCT06102902


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-01-29 @ 6:00 PM
Study NCT ID: NCT06102902
Status: RECRUITING
Last Update Posted: 2025-10-31
First Post: 2023-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Adenocarcinoma View
None Recurrent Colorectal Adenocarcinoma View
None Refractory Colorectal Adenocarcinoma View
None Stage IV Colorectal Cancer AJCC v8 View
Keywords: